Allianzgi Health Valuation

RCGHX Fund  USD 17.01  0.07  0.41%   
Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. Allianzgi Health Sciences prevailing Real Value cannot be determined due to lack of data. The current price of Allianzgi Health Sciences is $17.01. We determine the value of Allianzgi Health Sciences from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Undervalued
Today
17.01
Please note that Allianzgi Health's price fluctuation is out of control at this time. Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. Allianzgi Health Sciences prevailing Real Value cannot be determined due to lack of data. The current price of Allianzgi Health Sciences is $17.01. We determine the value of Allianzgi Health Sciences from analyzing fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we favor acquiring undervalued mutual funds and dropping overvalued mutual funds since, at some point, mutual fund prices and their ongoing real values will blend.
Since Allianzgi Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Allianzgi Mutual Fund. However, Allianzgi Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  17.01 Real  0.0 Hype  0.0 Naive  17.28
The intrinsic value of Allianzgi Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Allianzgi Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
0.00
Real Value
0.76
Upside
Estimating the potential upside or downside of Allianzgi Health Sciences helps investors to forecast how Allianzgi mutual fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Allianzgi Health more accurately as focusing exclusively on Allianzgi Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16.3016.8917.48
Details
Hype
Prediction
LowEstimatedHigh
0.000.000.76
Details
Naive
Forecast
LowNext ValueHigh
16.5217.2818.04
Details

Allianzgi Health Total Value Analysis

Allianzgi Health Sciences is at this time forecasted to have takeover price of 0 with market capitalization of 0, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Allianzgi Health fundamentals before making investing decisions based on enterprise value of the company

Allianzgi Health Asset Utilization

The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Allianzgi suggests not a very effective usage of assets in December.

About Allianzgi Health Valuation

Our relative valuation model uses a comparative analysis of Allianzgi Health. We calculate exposure to Allianzgi Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Allianzgi Health's related companies.
The fund seeks to achieve its objective by normally investing at least 80 percent of its net assets in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

Other Information on Investing in Allianzgi Mutual Fund

Allianzgi Health financial ratios help investors to determine whether Allianzgi Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allianzgi with respect to the benefits of owning Allianzgi Health security.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data